Food News and Research

RSS

Endologix announces initial PEVAR Trial presentation at 2011 iCON annual meeting

Endologix, developer of minimally invasive treatments for aortic disorders, announced today the presentation of the initial clinical results from the PEVAR Trial at the 2011 iCON annual meeting in Scottsdale, Arizona.

16 Feb 2011

ADVENTRX updates ANX-514 candidate for FDA approval

ADVENTRX Pharmaceuticals, Inc. today provided an update on its product candidate, ANX-514, its polysorbate 80-free formulation of docetaxel.

16 Feb 2011

Bioniche presentation focuses on implementing E. coli cattle vaccine to reduce risk of human infection

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, gave a presentation about its E. coli O157 cattle vaccine at the First International One Health Congress in Melbourne, Victoria, Australia.

16 Feb 2011

Republican leadership's FY11 budget cuts would endanger national security, Clinton says

"Secretary of State Hillary Rodham Clinton said Monday afternoon that the spending levels outlined by House Republicans late last week for the remainder of the fiscal year would endanger the country's national security," the Washington Post's "44" blog reports.

16 Feb 2011

CTI's fourth quarter net loss increases to $34.1 million

Cell Therapeutics, Inc. today reported recent accomplishments and financial results for the fourth quarter and year ended December 31, 2010.

16 Feb 2011

Also in global health news: Gates Foundation global health head to step down; drug, medical supply shortages in Gaza; food security in N. Korea

Tachi Yamada, president of the global health program at the Bill & Melinda Gates Foundation, on Monday announced he would step down in June after five years serving in the position, the Associated Press/Seattle Post-Intelligencer reports.

16 Feb 2011

Majority of parents continue to give OTC cough and cold medicines to children under 2

Research has linked over-the-counter cough and cold products to poisoning or death in hundreds of children, ages 2 and younger. Studies have also shown that these medicines do little to control symptoms. As a result, in 2008, the United States Food and Drug Administration formally recommended that OTC cough and cold products not be given to children under age 2.

16 Feb 2011

Study: Expedited medical device reviews account for majority of recalls

The analysis, which was published in the Archives of Internal Medicine, connected the Food and Drug Administration's most urgent medical device recalls with high-risk devices that were subject to "speedy" review.

16 Feb 2011

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Viral Genetics, Inc. announced today that lead researcher Dr. M. Karen Newell Rogers and Advisor Mr. Richard Gerstner will receive the Lauren F. Brooks Hope Award, presented by Time for Lyme, Inc.

16 Feb 2011

Fibrocell Science sells $7.8 million Series D convertible preferred stock

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that between December 8, 2010 and February 9, 2011 it entered into agreements with certain accredited investors, pursuant to which the Company sold to the purchasers in the aggregate approximately $7.8 million of the Company's Series D convertible preferred stock, which is convertible into shares of common stock at a conversion price of $0.50 per share.

16 Feb 2011

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

Researchers from Jefferson's Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial oxidative stress-a culprit in driving tumor growth.

16 Feb 2011

Aeolus receives BARDA contract for AEOL 10150 drug development against ARS

Aeolus Pharmaceuticals, a biopharmaceutical company developing a new class of broad spectrum catalytic antioxidant compounds that reduce oxidative stress, inflammation, and subsequent tissue damage-signaling cascades resulting from radiation exposure, today announced that the Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services, has awarded Aeolus a contract for the advanced development of AEOL 10150 as a medical countermeasure against the pulmonary sub-syndrome of acute radiation syndrome.

16 Feb 2011

Budget pushes health law implementation, provides some limited — but not easy — increases

However, news outlets report that funding gains within the Department of Health and Human Services come at a steep price.

16 Feb 2011

Covidien announces launch of TurboHawk Plaque Excision System for small vessels

Covidien, a leading global provider of healthcare products, today announced that it will launch the TurboHawk™ Plaque Excision System for small vessels next month in the United States and several international markets. The new system is intended to treat calcified and non-calcified lesion morphologies in small vessels, broadening minimally-invasive treatment options for Peripheral Arterial Disease (PAD).

16 Feb 2011

FDA grants 510(k) clearance to Venous Health's Vasculaire Compression System in the US

Venous Health Systems, a developer of solutions for treating vascular insufficiency by enhancing blood circulation, today announced that it has received 510 clearance from the Food & Drug Administration to market the Vasculaire Compression System in the United States.

15 Feb 2011

Calorie counts on menus do not impress teenagers: Study

US researchers have found that asking fast-food restaurants in New York City to display calorie counts on menus did not affect the number of calories children and teens consumed. The team of researchers said that while children and adolescents noticed the calories posted on the menu, they did not choose their order based on the calorie knowledge. Taste still took an upper hand in their choice.

15 Feb 2011

Efficacy of zinc in common cold - Review of clinical trials

A new study has added to the existing literature that debates the role of zinc in combating the common cold. It suggests that the supplement might modestly reduce cold duration and severity or maybe even prevent it. The report was published as a Cochrane Review.

15 Feb 2011

First Edition: February 15, 2011

Today's headlines include reports about the health portion of the President's budget blueprint along with the politics that accompany it.

15 Feb 2011

FDA clears ArthroCare's Spartan 5.5 Needled Anchor

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration for its Spartan 5.5 Needled Anchor. Spartan is a preloaded threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair.

15 Feb 2011

Food ingredients portfolio continues its geographical expansion

In 2011, the Food ingredients portfolio continues its geographical expansion and develops further with the industry it serves. Economic recovery, investment in emerging markets and focus on health characterise the industry this year.

15 Feb 2011

Food News and Research

Endologix announces initial PEVAR Trial presentation at 2011 iCON annual meeting

ADVENTRX updates ANX-514 candidate for FDA approval

Bioniche presentation focuses on implementing E. coli cattle vaccine to reduce risk of human infection

Republican leadership's FY11 budget cuts would endanger national security, Clinton says

CTI's fourth quarter net loss increases to $34.1 million

Also in global health news: Gates Foundation global health head to step down; drug, medical supply shortages in Gaza; food security in N. Korea

Majority of parents continue to give OTC cough and cold medicines to children under 2

Study: Expedited medical device reviews account for majority of recalls

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Fibrocell Science sells $7.8 million Series D convertible preferred stock

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

Aeolus receives BARDA contract for AEOL 10150 drug development against ARS

Budget pushes health law implementation, provides some limited — but not easy — increases

Covidien announces launch of TurboHawk Plaque Excision System for small vessels

FDA grants 510(k) clearance to Venous Health's Vasculaire Compression System in the US

Calorie counts on menus do not impress teenagers: Study

Efficacy of zinc in common cold - Review of clinical trials

First Edition: February 15, 2011

FDA clears ArthroCare's Spartan 5.5 Needled Anchor

Food ingredients portfolio continues its geographical expansion

Understanding cultivated meat and its global potential eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News